Hepatitis C News

• HCV-Positive Kidneys Cost-Effective for HCV-Positive Recipients Quality-adjusted life expectancy is greater and costs are lower when kidney transplant candidates infected with hepatitis C virus (HCV) receive HCV-positive kidneys than when they receive HCV-negative kidneys, according to a cost-effectiveness analysis.
  Reuters Health Information, July 2018
• Liver Cancer Doubled in High-Income Countries Rates of liver cancer have doubled since the 1990s in high-income countries and are largely due to infection with hepatitis B and C, as well as nonalcoholic fatty liver disease.
  Medscape Medical News, June 2018
• Sofosbuvir-Velpatasvir-Voxilaprevir Effective in Previously Treated Chronic Hep C
  Reuters Health Information, June 2018
• One-third of Patients Denied New Hepatitis C Drugs Despite an overall greater availability of direct-acting antivirals, absolute denials by insurers increased during 2016-2017 and remained high regardless of insurance type.
  Medscape Medical News, June 2018
• Extrahepatic Manifestations of Chronic Hep C Improve With Sustained Virological Response
  Reuters Health Information, May 2018
• HCV-associated Cryoglobulinemic Vasculitis Resolves After Virologic Cure
  Reuters Health Information, May 2018
• WHO Issues Its First List of Essential Diagnostic Tests The Essential Diagnostics List is a catalogue of the tests needed to diagnose the most common conditions as well as a number of global "priority" diseases.
  Medscape Medical News, May 2018
• Rates of HCV Screening Low Among Children Exposed in Pregnancy Hepatitis C virus (HCV) infection is on the rise among pregnant women due to the opioid epidemic, yet most perinatally infected children are flying under the radar due to insufficient screening, warn researchers from Pennsylvania in a new paper.
  Reuters Health Information, May 2018
• New Approach Identifies Infectious Causes of Chronic Meningitis
  Reuters Health Information, April 2018
• ACIP Recommends Heplisav-B Vaccine for Adults Heplisav-B, a yeast-derived hepatitis B vaccine made with a novel adjuvant, is recommended for individuals aged 18 years and older, according to the Advisory Committee on Immunization Practices.
  Medscape Medical News, April 2018
• Quick Portable Test Could Widen Reach of HCV Diagnosis
  Reuters Health Information, April 2018
• ISHLT 2018Hepatitis C-infected Heart and Lung Transplants Safe Organs donated from people infected with hepatitis C can be safely transplanted, and any transmission of the virus can be treated with antiretrovirals, new research shows.
  Medscape Medical News, April 2018
• ILC 2018Hep C Treatments Save Care Costs if Administered Early The early initiation of a pan-genotypic regimen lowers the cost of future care, report health economists who say current policies that base access to treatment on disease stage might be short-sighted.
  Medscape Medical News, April 2018
• Patient Advocacy Groups Take in Millions From Drugmakers. Is There Payback? Kaiser Health News launches 'Pre$cription for Power,' a groundbreaking database to expose Big Pharma’s ties to patient groups.
  Kaiser Health News, April 2018
• ILC 2018Liver Cancer on the Rise in Backdrop of Undiagnosed Hep C The hepatitis C epidemic that started in the 1950s infected many patients who are now developing end-stage liver cancer, and the number of cases is growing, researchers report.
  Medscape Medical News, April 2018
• ISHLT 2018Trailblazing Transplant Research Expanding Organ Options Heart donation after circulatory death and new insights into the suitability of organ donations will be debated at the upcoming heart and lung transplantation scientific sessions.
  Medscape Medical News, April 2018
• Glecaprevir/pibrentasvir Treats Hepatitis C in HIV-coinfected Individuals The direct-acting antiviral (DAA) combination glecaprevir/pibrentasvir is effective for treating hepatitis C virus (HCV) infection in individuals coinfected with HIV-1, according to results from the non-randomized, open-label phase 3 EXPEDITION-2 trial.
  Reuters Health Information, April 2018
• Resection Bests Chemoembolization in Selected Liver Cancer Patients Resection offers survival benefits in carefully selected patients with intermediate-to-advanced hepatocellular carcinoma (HCC), researchers in Korea suggest.
  Reuters Health Information, March 2018
• Alcohol-Related Liver Cancer Diagnosed at Later Stages Liver cancer related to alcohol consumption is assosciated with worse outcomes than other types of liver cancer, primarily owing to later diagnosis.
  Medscape Medical News, March 2018
• Prior Chlamydia Infection and Doubled Risk for Ovarian Cancer Pelvic inflammatory disease, which is often caused by sexually transmitted disease, increases ovarian cancer risk; Chlamydia appears to double the risk.
  Medscape Medical News, March 2018